Announcements Trials
Browse Landscape

Status

Recruiting 5Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 120Carcinoma, Non-Small-Cell Lung 107Prostatic Neoplasms 92Multiple Myeloma 77Neoplasms 75Lung Neoplasms 64Colorectal Neoplasms 51Leukemia, Myeloid, Acute 45Neoplasm Metastasis 43Pancreatic Neoplasms 39Melanoma 39Lymphoma 39Lymphoma, Non-Hodgkin 38Carcinoma, Renal Cell 38Ovarian Neoplasms 35Leukemia, Lymphocytic, Chronic, B-Cell 33Squamous Cell Carcinoma of Head and Neck 32Urinary Bladder Neoplasms 31Hematologic Neoplasms 29Precursor Cell Lymphoblastic Leukemia-Lymphoma 28Endometrial Neoplasms 28Uterine Cervical Neoplasms 26Triple Negative Breast Neoplasms 25Carcinoma, Hepatocellular 25Sarcoma 24Glioma 24Brain Neoplasms 24Stomach Neoplasms 23Recurrence 22Head and Neck Neoplasms 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Adrenal Gland Neoplasms × 30 days × Clear all
NCT00568139 2026-05-07

Evaluation of Side Effects of Mitotane

University of Wuerzburg

Active not recruiting
400 enrolled
Endocrine

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡